Radboudumc is the first hospital in the world to use a new genetic test on a large scale in clinical practice. This test provides more people with a diagnosis for rare conditions and is faster and ...

The trial is a phase 1/2 open-label, ascending-dose study of the safety and efficacy of OPGx-LCA5. Recently, the company ...

Genetic differences in early- and late-onset depression highlight distinct risk profiles, informing targeted strategies for ...

Radboudumc and Maastricht UMC+ are the first hospitals in the world to use a new genetic test to diagnose rare diseases on a ...

Preterm babies face greater health risks from the moment they are born. Their organs, immune systems, and metabolic pathways are not fully developed, making them more vulnerable to complications.

Baylor College of Medicine’s Center for Precision Medicine Models has received a five-year, $10 million grant from the ...

The American College of Medical Genetics and Genomics (ACMG) has published a new clinical practice resource, "Management of ...

These genes are strongly associated with cancer risk and may have clear clinical actionability, supporting the goal that each addition to the panel provides meaningful insights for patient care. The ...

In this GEN webinar, experts from Sampled and Rady Children’s Hospital will discuss the validation and clinical integration ...

Patients with kidney disease are largely unaware of genetic testing opportunities, according to data presented at ASN Kidney ...